Cargando…

372. Comparing the Outcome of COVID-19 in Cancer and Non-Cancer Patients: an International Multicenter Study

BACKGROUND: Our objective was to describe the clinical course, risk factors and outcomes of patients infected with COVID-19 around the globe comparing cancer to non-cancer patients. METHODS: We conducted a retrospective cohort study of COVID-19 confirmed cases through an international multicenter co...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hachem, Ray Y, Datoguia, Tarcila, Siddiqui, Bilal, Cruz, Ana Fernandez, Mori, Nobuyoshi, Fakhreddine, Suha, Lee, Dong-Gun, Gorak, Edward, Somer, Robert, Bhinder, Arvinder, Shelanski, Samuel, Dragivich, Tomislav, Bayle, Arnaud, Chemaly, Roy F, Mulonovich, Victor, Adachi, Javier, Malek, Alexandre, Slavin, Monica, Jiang, Ying, Chaftari, Anne-Marie, Raad, Issam I
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Poster Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7776865/ http://dx.doi.org/10.1093/ofid/ofaa439.567

Ejemplares similares

293. Lung Cancer and Hematologic Malignancy ( HM) Patients Are Associated with the Highest Risk of Progressing to Severe Disease and Mortality in Cancer Patients with COVID-19
por: Chaftari, Anne-Marie, et al.
Publicado: (2021)

22. International Multicenter Study Comparing Cancer to Non-Cancer Patients with COVID-19: Impact of Risk Factors and Treatment Modalities on Outcome
por: Hachem, Ray Y, et al.
Publicado: (2021)

1228. The Role of Procalcitonin (PCT) and Lactic Acid in Febrile Neutropenic Cancer Patients in an Oncological Emergency Center
por: Chaftari, Patrick, et al.
Publicado: (2020)

1257. A phase II Prospective Randomized Study to Assess Ceftolozane-Tazobactam in the Management of Febrile Neutropenia in Patients with Hematological Malignancies
por: Chaftari, Anne-Marie, et al.
Publicado: (2020)

International multicenter study comparing COVID-19 in patients with cancer to patients without cancer: Impact of risk factors and treatment modalities on survivorship
por: Raad, Issam I, et al.
Publicado: (2023)

1636. Risk of Latent Tuberculosis Reactivation in Patients Treated with Checkpoint Inhibitors Immunotherapy Compared to Other Anti-Cancer Therapies including Hematopoietic Cell Transplantation
por: Malek, Alexandre, et al.
Publicado: (2020)

Appropriate Duration of Intravenous Treatment of Candidemia and Timing of Step Down to Oral Therapy in Non-neutropenic Patients
por: Dib, Rita Wilson, et al.
Publicado: (2018)

1182. The Real-World Use of Isavuconazole as Primary or salvage Therapy of Invasive Fungal infections in High-Risk Patients with Hematologic Malignancy or Stem Cell Transplant
por: dagher, Hiba, et al.
Publicado: (2020)

357. A Comparison of Chest CT Findings in Cancer and Non-Cancer Patients with COVID-19
por: Malek, Alexandre, et al.
Publicado: (2021)

528. Matched Retrospective Study, Comparing Molnupiravir to Nirmatrelvir-Ritonavir (Paxlovid) in the Treatment of Mild-Moderate COVID-19 in Immunocompromised Cancer Patients
por: Haddad, Andrea, et al.
Publicado: (2023)

Procalcitonin Guiding Antimicrobial Therapy Duration in Febrile Cancer Patients with Documented Infection or Neutropenia
por: Haddad, Hanine El, et al.
Publicado: (2018)

Author Correction: Procalcitonin Guiding Antimicrobial Therapy Duration in Febrile Cancer Patients with Documented Infection or Neutropenia
por: El Haddad, Hanine, et al.
Publicado: (2018)

Comparative Efficacies of Antimicrobial Catheter Lock Solutions for Fungal Biofilm Eradication in an in Vitro Model of Catheter-Related Fungemia
por: Rosenblatt, Joel, et al.
Publicado: (2017)

Catheter-Related Staphylococcus aureus Bacteremia and Septic Thrombosis: The Role of Anticoagulation Therapy and Duration of Intravenous Antibiotic Therapy
por: Wilson Dib, Rita, et al.
Publicado: (2018)

1171. Impact of Catheter Management on the Clinical Outcome in Adult Cancer Patients with Gram-Negative Bacteremia
por: Fares, Johny, et al.
Publicado: (2019)

Impact of Catheter Management on Clinical Outcome in Adult Cancer Patients With Gram-Negative Bacteremia
por: Fares, Johny, et al.
Publicado: (2019)

810. Resistance to the Minocycline-Rifampin-Chlorhexidine (MRCH) combination does not emerge in biofilms of Tetracycline and Rifampin resistant bacteria grown on MRCH catheters depleted below antimicrobially effective concentrations
por: Gerges, Bahgat, et al.
Publicado: (2020)

The use of minocycline-rifampin coated central venous catheters for exchange of catheters in the setting of staphylococcus aureus central line associated bloodstream infections
por: Chaftari, Anne-Marie, et al.
Publicado: (2014)

Caprylic and Polygalacturonic Acid Combinations for Eradication of Microbial Organisms Embedded in Biofilm
por: Rosenblatt, Joel, et al.
Publicado: (2017)

Foley Catheter with Peri-Urethral Antimicrobial Irrigation for the Prevention of Catheter Associated Urinary Tract Infections – Assessment in an In Vitro Model
por: Rosenblatt, Joel, et al.
Publicado: (2017)

Comparing Diagnostic-Driven Approaches to Empiric Therapy in the Treatment of Invasive Aspergillosis in Patients with Hematologic Malignancy
por: Dib, Rita Wilson, et al.
Publicado: (2017)

1709 Mycobacterium Arupense in Cancer Patients: A Commensal Organism or a Pathogen?
por: Jordan, Mary, et al.
Publicado: (2014)

Treating invasive aspergillosis in patients with hematologic malignancy: diagnostic-driven approach versus empiric therapies
por: Dib, Rita Wilson, et al.
Publicado: (2018)

2099. Catheter-related Staphylococcus aureus Bacteremia and Septic Thrombosis: The Role of Anticoagulation and Duration of Intravenous Antibiotic Therapy
por: Dib, Rita Wilson, et al.
Publicado: (2018)

Pilot Ex Vivo and In Vitro Evaluation of a Novel Foley Catheter with Antimicrobial Periurethral Irrigation for Prevention of Extraluminal Biofilm Colonization Leading to Catheter-Associated Urinary Tract Infections (CAUTIs)
por: Vargas-Cruz, Nylev, et al.
Publicado: (2019)

Unnecessary Removal of Central Venous Catheters in Cancer Patients with Bloodstream Infections: Impact on Symptom Burden
por: Chaftari, Anne-Marie, et al.
Publicado: (2017)

Catheter-related Complications and Potential Risk Factors Among Catheterized Cancer Patients Receiving Parenteral Nutrition at The University of Texas MD Anderson Cancer Center: A 26,000 Parenteral Nutrition-day Experience
por: Reitzel, Ruth, et al.
Publicado: (2017)

Challenge of hepatitis C in Egypt and hepatitis B in Mauritania
por: Raad, Issam I, et al.
Publicado: (2018)

Catheter Lock with Minocycline, EDTA and Ethanol for Salvaging of Central Venous Catheters in the Setting of Catheter-related Bloodstream Infections
por: Hachem, Ray Y, et al.
Publicado: (2017)

International Multicenter Experience in the Treatment Outcome of Invasive Aspergillosis in Immunocompromised Cancer Patients
por: Hachem, Ray, et al.
Publicado: (2019)

Real-World Use of Isavuconazole as Primary Therapy for Invasive Fungal Infections in High-Risk Patients with Hematologic Malignancy or Stem Cell Transplant
por: Dagher, Hiba, et al.
Publicado: (2022)

Novel plasma telomerase detection method to improve cancer diagnostic assessment
por: Hilal, George, et al.
Publicado: (2017)

Management of enterococcal central line-associated bloodstream infections in patients with cancer
por: Awadh, Hesham, et al.
Publicado: (2021)

2122. In Vitro Activity of Cefepime-Taniborbactam Against Clinically Significant Gram-Negative Bacteria Isolated from Patients with Cancer
por: Gerges, Bahgat Z, et al.
Publicado: (2023)

2453. Repeated Exposures to Minocycline/Rifampin and + Chlorhexidine Combination Used to Coat Catheters Fails to Induce Antimicrobial Resistance
por: Vargas-Cruz, Nylev, et al.
Publicado: (2018)

1488. Invasive Pulmonary Aspergillosis in Patients with Solid Tumors: Risk Factors and Predictors of Clinical Outcomes
por: Dandachi, Dima, et al.
Publicado: (2018)

120. The Impact of Early Central Venous Catheter Removal in the Management of Enterococcus Central Line-Associated Bloodstream Infections
por: Awadh, Hesham, et al.
Publicado: (2019)

272. Invasive Pulmonary Aspergillosis: Comparative Analysis in cancer patients with Underlying Hematologic Malignancy vs. Solid Tumor
por: Wilson Dib, Rita, et al.
Publicado: (2019)

Prognostic Value of Procalcitonin, C-Reactive Protein, and Lactate Levels in Emergency Evaluation of Cancer Patients with Suspected Infection
por: Chaftari, Patrick, et al.
Publicado: (2021)

356. The Role of Procalcitonin in Antimicrobial Stewardship Among Cancer Patients Admitted with COVID-19
por: Dagher, Hiba, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_67mmv2viddu6rrdes8fb1j1896